Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 40/100

Failure Rate

14.3%

1 terminated/withdrawn out of 7 trials

Success Rate

83.3%

-3.2% vs industry average

Late-Stage Pipeline

43%

3 trials in Phase 3/4

Results Transparency

40%

2 of 5 completed trials have results

Key Signals

2 with results

Enrollment Performance

Analytics

N/A

4(57.1%)

Phase 4

2(28.6%)

Phase 3

1(14.3%)

7Total

N/A(4)

Phase 4(2)

Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials

NCT04951206Phase 4Completed

Fractionated CO2 Laser With and Without Clobetasol for Treatment of Vulvar Lichen Sclerosus

Role: collaborator

NCT05540353Not ApplicableTerminated

Transvaginal Low-level Laser Therapy to Improve Pelvic Pain and Sexual Function in Patients with Endometriosis.

Role: collaborator

NCT03568708Phase 3Completed

Primary Ovarian Insufficiency: Phenotype and Optimal Treatment

Role: collaborator

NCT02865187Not ApplicableCompleted

Evaluation of Vitamin D in Women With PCOS and Sexual Dysfunction

Role: collaborator

NCT02287519Not ApplicableCompleted

Sexual Therapy and Rehabilitation After Treatment for Ovarian Cancer (START-OC): A Pilot Intervention

Role: collaborator

NCT02261740Not ApplicableCompleted

Program to Overcome Pelvic Pain With Yoga

Role: collaborator

NCT02022722Phase 4Unknown

Trigger Point Injections and Pelvic Rehabilitation for the Treatment of Pelvic Floor Myalgia and Sexual Pain

Role: collaborator

All 7 trials loaded